Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Treatment of Refractory Infantile Spasms With Fenfluramine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fenfluramine for refractory infantile spasms is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenfluramine (fenfluramine)

Snippet

Sponsor: Children's Hospital of Orange County | Conditions: Infantile Spasm | Phase 2 | Status: RECRUITING